Difference between revisions of "Von Willebrand factor"
| Line 35: | Line 35: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1auq.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1auq.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 10:55, 25 July 2007
| Template:Infobox header| Von Willebrand factor | |
|---|---|
| Von Willebrand factor | |
| Substrate peptide name | Von Willebrand factor |
| Synonyms | - |
| Determination type | In vitro |
| Source | Bos taurus |
| Subcellular localization | Extracellualr;Plasma |
| Swissprot ID | P80012 |
| Reactive glutamines | Q313, Q509, Q560, Q634 |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | 1AUQ |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:8099582 |
| Notes | |
| Template:Infobox header | | |
